Valved Graft PMCF Study
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorAbbott Medical Devices
About this trial
Multicenter, global, prospective, non-randomized, interventional, post-market trial. All subjects enrolled will receive an Abbott Valved Graft device.
Eligibility criteria
Qualifiers
cardiac surgery including the implant of a VAVGJ or CAVGJ for native or prosthetic valve replacement
Disqualifiers
anticoagulation therapy intolerant
active endocarditis
anatomical or medical, surgical, psychological or social contraindications
Trial design
Treatments tested in this trial
- VAVGJ
- CAVGJ
Treatment groups
260 Participants
are divided into 2 treatment groupsLocations
25Austria
Klinik Floridsdorf1012, Vienna Austria
Denmark
Rigshospitalet2100, Copenhagen Denmark
France
CHU de Besancon - Jean Minjoz25030, Besançon France
CHRU Lille59037, Lille France
Sponsors and collaborators
Abbott Medical Devices
Lead sponsor
Source ClinicalTrials.gov